Crown Technology

Crown Bioscience is a global drug discovery and development service company providing translational platforms to advance oncology, inflammation, cardiovascular, and metabolic disease research. As a leading Contract Research Organization (CRO), the company specializes in providing high-quality preclinical models and services, including the world's largest collection of Patient-Derived Xenograft (PDX) models. Crown Bioscience supports pharmaceutical and biotechnology companies by offering integrated solutions that bridge the gap between preclinical research and clinical success. Their expertise spans across efficacy testing, biomarker discovery, and personalized medicine applications.